Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 252

1.

High expression levels of egfl7 correlate with low endothelial cell activation in peritumoral vessels of human breast cancer.

Pannier D, Philippin-Lauridant G, Baranzelli MC, Bertin D, Bogart E, Delprat V, Villain G, Mattot V, Bonneterre J, Soncin F.

Oncol Lett. 2016 Aug;12(2):1422-1428. Epub 2016 Jun 28.

2.

Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study.

Bertucci F, Fekih M, Autret A, Petit T, Dalenc F, Levy C, Romieu G, Bonneterre J, Ferrero JM, Kerbrat P, Soulie P, Mouret-Reynier MA, Bachelot T, Lerebours F, Eymard JC, Deblock M, Lortholary A, Hardy-Bessard AC, Barthelemy P, Bonnefoi H, Charafe-Jauffret E, Bidard FC, Viens P, Lemonnier J, Pierga JY.

Lancet Oncol. 2016 May;17(5):600-11. doi: 10.1016/S1470-2045(16)00011-5. Epub 2016 Mar 28.

PMID:
27032301
3.

Analysis of Arrestin Recruitment to Chemokine Receptors by Bioluminescence Resonance Energy Transfer.

Bonneterre J, Montpas N, Boularan C, Galés C, Heveker N.

Methods Enzymol. 2016;570:131-53. doi: 10.1016/bs.mie.2015.09.003. Epub 2015 Nov 29.

PMID:
26921945
4.

Value of a gene signature assay in patients with early breast cancer and intermediate risk: a single institution retrospective study.

Bonneterre J, Prat A, Galván P, Morel P, Giard S.

Curr Med Res Opin. 2016 May;32(5):835-9. doi: 10.1185/03007995.2016.1146664. Epub 2016 Feb 12.

PMID:
26809116
5.

ERCC1 and CYP1B1 polymorphisms as predictors of response to neoadjuvant chemotherapy in estrogen positive breast tumors.

Dumont A, Pannier D, Ducoulombier A, Tresch E, Chen J, Kramar A, Révillion F, Peyrat JP, Bonneterre J.

Springerplus. 2015 Jul 7;4:327. doi: 10.1186/s40064-015-1053-0. eCollection 2015.

6.

A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy.

Le Rhun E, Delbeuck X, Lefeuvre-Plesse C, Kramar A, Skrobala E, Pasquier F, Bonneterre J.

Breast Cancer Res Treat. 2015 Aug;152(3):569-80. doi: 10.1007/s10549-015-3493-1. Epub 2015 Jul 11.

PMID:
26160250
7.

Development of a technique to detect the activated form of the progesterone receptor and correlation with clinical and histopathological characteristics of endometrioid adenocarcinoma of the uterine corpus.

Bonneterre J, Hutt E, Bosq J, Graham JD, Powell MA, Leblanc E, Fujiwara K, Herzog TJ, Coleman RL, Clarke CL, Gilles EM, Zukiwski AA, Monk BJ.

Gynecol Oncol. 2015 Sep;138(3):663-7. doi: 10.1016/j.ygyno.2015.06.037. Epub 2015 Jul 2.

PMID:
26142884
8.

Prolonged Response and Restoration of Functional Independence with Bevacizumab plus Vinorelbine as Third-Line Treatment for Breast Cancer-Related Leptomeningeal Metastases.

Le Rhun E, Taillibert S, Boulanger T, Zairi F, Bonneterre J, Chamberlain MC.

Case Rep Oncol. 2015 Feb 12;8(1):72-7. doi: 10.1159/000375293. eCollection 2015 Jan-Apr.

9.

[Systemic treatment of brain metastases from breast cancer].

Taillibert S, Conforti R, Bonneterre J, Bachelot T, Le Rhun E, Bernard-Marty C.

Cancer Radiother. 2015 Feb;19(1):36-42. doi: 10.1016/j.canrad.2014.12.003. Epub 2015 Feb 7. Review. French.

PMID:
25662600
10.

Pathological response and circulating tumor cell count identifies treated HER2+ inflammatory breast cancer patients with excellent prognosis: BEVERLY-2 survival data.

Pierga JY, Petit T, Lévy C, Ferrero JM, Campone M, Gligorov J, Lerebours F, Roché H, Bachelot T, Charafe-Jauffret E, Bonneterre J, Hernandez J, Bidard FC, Viens P.

Clin Cancer Res. 2015 Mar 15;21(6):1298-304. doi: 10.1158/1078-0432.CCR-14-1705. Epub 2014 Dec 23.

11.

Brain Metastases of Her2-Positive Breast Cancer: A Case of 34 Months' Remission with Lapatinib plus Capecitabine.

Mailliez A, Servent V, Bonneterre J, Le Rhun E.

Case Rep Oncol. 2014 Aug 7;7(2):555-9. doi: 10.1159/000365747. eCollection 2014 May.

12.

Decrease social inequalities return-to-work: development and design of a randomised controlled trial among women with breast cancer.

Vidor C, Leroyer A, Christophe V, Seillier M, Foncel J, Van de Maële J, Bonneterre J, Fantoni S.

BMC Cancer. 2014 Apr 17;14:267. doi: 10.1186/1471-2407-14-267.

13.

A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC).

Awada A, Bondarenko IN, Bonneterre J, Nowara E, Ferrero JM, Bakshi AV, Wilke C, Piccart M; CT4002 study group.

Ann Oncol. 2014 Apr;25(4):824-31. doi: 10.1093/annonc/mdu025.

14.

Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER).

André F, Bachelot T, Commo F, Campone M, Arnedos M, Dieras V, Lacroix-Triki M, Lacroix L, Cohen P, Gentien D, Adélaide J, Dalenc F, Goncalves A, Levy C, Ferrero JM, Bonneterre J, Lefeuvre C, Jimenez M, Filleron T, Bonnefoi H.

Lancet Oncol. 2014 Mar;15(3):267-74. doi: 10.1016/S1470-2045(13)70611-9. Epub 2014 Feb 7.

PMID:
24508104
15.

CSF CA 15-3 in breast cancer-related leptomeningeal metastases.

Le Rhun E, Kramar A, Salingue S, Girot M, Rodrigues I, Mailliez A, Zairi F, Bakhache E, Robin YM, Taillibert S, Dubois F, Bonneterre J, Chamberlain MC.

J Neurooncol. 2014 Mar;117(1):117-24. doi: 10.1007/s11060-014-1361-1. Epub 2014 Jan 28.

PMID:
24469852
16.

[What do clinicians do with the results of the systematic staging imaging at the time of the breast cancer diagnosis?].

Turpin A, Mailliez A, Vennin P, Bonneterre J.

Gynecol Obstet Fertil. 2014 May;42(5):325-30. doi: 10.1016/j.gyobfe.2013.11.006. Epub 2014 Jan 7. French.

PMID:
24411340
17.

Salvage intracerebrospinal fluid thiotepa in breast cancer-related leptomeningeal metastases: a retrospective case series.

Le Rhun E, Taillibert S, Devos P, Zairi F, Turpin A, Rodrigues I, Cazin JL, Pierret MF, André C, Dubois F, Bonneterre J, Chamberlain MC.

Anticancer Drugs. 2013 Nov;24(10):1093-7. doi: 10.1097/CAD.0000000000000010.

PMID:
23962903
18.

A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancer.

Martin M, Bonneterre J, Geyer CE Jr, Ito Y, Ro J, Lang I, Kim SB, Germa C, Vermette J, Wang K, Wang K, Awada A.

Eur J Cancer. 2013 Dec;49(18):3763-72. doi: 10.1016/j.ejca.2013.07.142. Epub 2013 Aug 15.

PMID:
23953056
19.

Prolonged survival of patients with breast cancer-related leptomeningeal metastases.

Le Rhun E, Taillibert S, Zairi F, Pannier D, Boulanger T, Andre C, Cazin JL, Dubois F, Bonneterre J, Chamberlain MC.

Anticancer Res. 2013 May;33(5):2057-63.

PMID:
23645756
20.

Results and consequence of the systematic staging imaging at the time of the breast cancer diagnosis.

Mailliez A, Turpin A, Vennin P, Bonneterre J.

Breast. 2013 Aug;22(4):555. doi: 10.1016/j.breast.2013.03.007. Epub 2013 Apr 18. No abstract available.

PMID:
23602423
Items per page

Supplemental Content

Loading ...
Write to the Help Desk